| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 602 | 36.062 | 11.846 | 14.374 | 27.414 |
| Total Income - EUR | - | - | - | - | - | 602 | 36.174 | 11.832 | 14.284 | 27.414 |
| Total Expenses - EUR | - | - | - | - | - | 2.808 | 30.112 | 9.490 | 24.418 | 29.962 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -2.206 | 6.062 | 2.341 | -10.134 | -2.548 |
| Net Profit/Loss - EUR | - | - | - | - | - | -2.206 | 5.751 | 2.241 | -10.277 | -2.598 |
| Employees | - | - | - | - | - | 2 | 1 | 1 | 3 | 2 |
Check the financial reports for the company - Kolibri Biosun S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 5.699 | 14.767 | 18.638 | 27.560 | 15.081 |
| Inventories | - | - | - | - | - | 4.605 | 2.264 | 3.465 | 3.860 | 2.507 |
| Receivables | - | - | - | - | - | 1.007 | 7.838 | 14.745 | 15.385 | 7.522 |
| Cash | - | - | - | - | - | 86 | 4.666 | 428 | 8.316 | 5.053 |
| Shareholders Funds | - | - | - | - | - | -2.165 | 3.497 | 5.749 | -4.545 | -7.118 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 7.864 | 11.270 | 12.889 | 32.106 | 22.199 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9623 - 9623" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Kolibri Biosun S.r.l.